SecBot SecBot
425 ·Filed Jun 26, 2026

AXTA

Axalta Coating Systems Ltd.
BULLISH
Impact 6/10
Horizonweeks Processed4mo ago SEC0000950103-26-009534
Rule 425 M&A communications
Actionable Insight ▲ Bullish

The shareholder vote on August 5, 2026, is the next major catalyst. With the Foundation's priority shares already committed to vote in favor and AkzoNobel management unanimously recommending the deal, path to completion appears high. The EUR 150 million termination fee (relative to $7.4 billion market cap) provides modest deal protection. Regulatory approvals across multiple jurisdictions (EU, UK, US) remain outstanding, any material condition or required divestiture could delay or alter terms. The EUR 2.5 billion special dividend is a significant cash return to AkzoNobel shareholders pre-closing.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$34.50
T+0 close · Jun 26, 2026 · via day close
Latest settled
−7.95%
T+60 · $31.76
Vs SPY
−14.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 26 $34.50entry
  2. T+1 · 5mo ago −1.42%α −3.07% · $34.01
  3. T+5 · 4mo ago +1.77%α −0.40% · $35.11
  4. T+20 · 4mo ago −8.17%α −9.43% · $31.68
  5. T+60 · 8w ago −7.95%α −14.05% · $31.76
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Akzo Nobel N.V. issued a definitive shareholder circular convening an extraordinary general meeting (EGM) on August 5, 2026, to approve the all-share merger of equals with Axalta Coating Systems Ltd. The circular provides the complete technical framework for the merger vote, including the fixed exchange ratio of 0.6539 AkzoNobel shares per Axalta share, a special pre-completion dividend of EUR 2.5 billion to AkzoNobel shareholders, and pro forma financials showing combined revenue of ~$17 billion, adjusted EBITDA of $3.3 billion, and ~$600 million in pre-tax run-rate synergies. This filing advances the deal toward the shareholder vote and includes confidence-boosting details like fairness opinions from Morgan Stanley and Lazard, but no new substantive changes to deal terms.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Axa shareholders to receive 0.6539 AkzoNobel ordinary shares per Axalta common share (fixed exchange ratio, no collar).
  • AkzoNobel shareholders to hold ~55% of MergeCo on a pro forma basis; Axalta shareholders ~45%.
  • AkzoNobel declares a special pre-completion cash dividend of EUR 2.5 billion (minus 2026 interim dividends already paid).
  • Pro forma MergeCo expected to generate ~$17 billion revenue, $3.3 billion adjusted EBITDA, and $1.5 billion adjusted free cash flow.
  • Expected pre-tax run-rate synergies of ~$600 million, with 90% expected within three years of closing.
  • Both AkzoNobel and Axalta shareholder meetings scheduled for August 5, 2026; closing expected late 2026 to early 2027.
  • AkzoNobel receives fairness opinions from Morgan Stanley and Lazard that the Exchange Ratio is fair from a financial point of view to AkzoNobel.
  • AkzoNobel would pay a EUR 150 million termination fee if the board changes its recommendation; Axalta can terminate for a superior proposal.
  • Merger sub 1 (Bermuda) will merge into Axalta; post-closing, Axalta merges into Merger Sub 2, a direct wholly-owned subsidiary of AkzoNobel.
  • MergeCo will have dual headquarters in Amsterdam and Philadelphia; initially listed on NYSE and Euronext Amsterdam, with Euronext delisting expected after ~12 months.

Financial Impact

Pro forma MergeCo expected to generate approximately $17 billion in revenue, $3.3 billion in adjusted EBITDA, and $1.5 billion in adjusted free cash flow; pre-tax run-rate synergies estimated at $600 million, with 90% achieved within three years. AkzoNobel to distribute EUR 2.5 billion special dividend prior to completion.

revenuesynergiesebitdafree cash flowdilutionshare count

Risk Factors

  • Regulatory approvals (merger control in EU, UK, US; FDI filings; Foreign Subsidies Regulation) may impose conditions or fail to materialize
  • Shareholders of either company may vote against the merger
  • Integration of two large cross-border businesses carries execution risk; expected synergies may fail to materialize
  • Fixed exchange ratio exposes AkzoNobel shareholders to relative stock price movements adverse to AkzoNobel
  • AkzoNobel may be required to pay EUR 150 million termination fee if board changes recommendation
  • Euronext Amsterdam de-listing ~12 months post-closing adds risk of reduced European shareholder base

Market Snapshot

Exchange
NYSE
Sector
Paints, Varnishes, Lacquers, Enamels & Allied Prods
Analyst Consensus
52% bullish (21 analysts)

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0000950103-26-009534
Document: 0000950103-26-009534-index-headers.html0000950103-26-009534
Document: 0000950103-26-009534-index.html0000950103-26-009534
Document: 0000950103-26-009534.txt0000950103-26-009534

Track record

44 reports on AXTA

Performance horizon

5 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +16.39% at T+60 after the Jun 3, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry price pending
  2. Nov 12, 20264d ago SC 13G Neutral 3/10 Entry $36.41 to $36.56 Now $36.56 +0.41% ▲ +0.41% +0.78% vs SPY
  3. Nov 12, 20264d ago 425 Neutral 4/10 Entry $36.41 to $36.56 Now $36.56 +0.41% ▲ +0.41% +0.78% vs SPY
  4. Nov 12, 20264d ago 425 Neutral 4/10 Entry $36.41 to $36.56 Now $36.56 +0.41% ▲ +0.41% +0.78% vs SPY
  5. Nov 11, 20265d ago Press Release Neutral 4/10 Entry $37.07 to $36.41 Now $36.56 −1.38% ▼ −1.78% −1.43% vs SPY
  6. Nov 6, 202610d ago 425 Neutral 5/10 Entry $37.53 to $37.38 Now $36.56 −2.58% ▼ −0.40% −0.03% vs SPY
  7. Nov 6, 202610d ago 425 Bullish 6/10 Entry $36.45 to $37.53 Now $36.56 +0.30% ▲ +2.96% +0.60% vs SPY
  8. Nov 6, 202610d ago Press Release Bullish 5/10 Entry $36.45 to $37.53 Now $36.56 +0.30% ▲ +2.96% +0.60% vs SPY
  9. Oct 29, 202618d ago 425 Bearish 4/10 Entry $34.07 to $35.84 Now $36.56 −7.31% ▼ −5.20% −5.67% vs SPY
  10. Oct 29, 202618d ago 425 Neutral 4/10 Entry $34.07 to $35.84 Now $36.56 +7.31% ▲ +5.20% +5.67% vs SPY
Showing 10 of 44

US Market Status

Market Closed · Opens Wed (12h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026